ETHZ Key Statistics, Chart & Performance
The current stock price of ETHZ is 10.68 USD. In the past month the price decreased by -46.79%.
ETHZ Latest News, Press Relases and Analysis
ETHZ Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.1 | 402.43B | ||
| AMGN | AMGEN INC | 15.8 | 186.02B | ||
| GILD | GILEAD SCIENCES INC | 15.37 | 156.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.98 | 110.02B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.33 | 82.00B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 884.76 | 59.61B | ||
| INSM | INSMED INC | N/A | 44.31B | ||
| NTRA | NATERA INC | N/A | 32.96B | ||
| BIIB | BIOGEN INC | 10.88 | 26.71B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.42 | 20.93B | ||
| INCY | INCYTE CORP | 16.27 | 20.51B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.22B |
Related stock screener links
About ETHZ
Company Profile
ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palm Beach, Florida. The company went IPO on 2017-06-07. The firm offers tokenization solutions, DeFi protocol integration, blockchain analytics, traditional to digital asset conversion gateways, and other decentralized finance services. The company connects financial institutions, businesses and organizations worldwide by accessible blockchain transactions through Ethereum Network protocol implementations and various DeFi protocols. The company brings traditional assets on chain by tokenization and through its proprietary protocol implementations. The firm facilitates DeFi transactions and asset digitization across multiple Layers 2 Ethereum networks.
Company Info
ETHZILLA CORP
2875 South Ocean, Suite 200
Palm Beach FLORIDA US
Employees: 4
Phone: 16505070669
ETHZILLA CORP / ETHZ FAQ
Can you describe the business of ETHZILLA CORP?
ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palm Beach, Florida. The company went IPO on 2017-06-07. The firm offers tokenization solutions, DeFi protocol integration, blockchain analytics, traditional to digital asset conversion gateways, and other decentralized finance services. The company connects financial institutions, businesses and organizations worldwide by accessible blockchain transactions through Ethereum Network protocol implementations and various DeFi protocols. The company brings traditional assets on chain by tokenization and through its proprietary protocol implementations. The firm facilitates DeFi transactions and asset digitization across multiple Layers 2 Ethereum networks.
What is the stock price of ETHZILLA CORP today?
The current stock price of ETHZ is 10.68 USD. The price increased by 0.56% in the last trading session.
Does ETHZ stock pay dividends?
ETHZ does not pay a dividend.
How is the ChartMill rating for ETHZILLA CORP?
ETHZ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists ETHZ stock?
ETHZ stock is listed on the Nasdaq exchange.
How is the valuation of ETHZILLA CORP (ETHZ) based on its PE ratio?
ETHZILLA CORP (ETHZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-127.78).
Who owns ETHZILLA CORP?
You can find the ownership structure of ETHZILLA CORP (ETHZ) on the Ownership tab.
ETHZ Technical Analysis
ETHZ Financial Highlights
Over the last trailing twelve months ETHZ reported a non-GAAP Earnings per Share(EPS) of -127.78. The EPS increased by 54.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -160.73% | ||
| ROE | -320.05% | ||
| Debt/Equity | 0.12 |